Evidence map›Paper›PMID 25174457›Full record

ArticleIntegrative biology : quantitative biosciences from nano to macro2014

Combinative in vitro studies and computational model to predict 3D cell migration response to drug insult.

Joseph S Maffei, Jaya Srivastava, Brian Fallica, Muhammad H Zaman

Open access · bronzeAbstract read
In one paragraph

Article in Integrative biology : quantitative biosciences from nano to macro, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.3field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Review
  3. Modeling the Leukemia MicroenviromentFrontiers in oncology · 2020
    Review
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Joseph S MaffeiDepartment of Biomedical Engineering, Boston University, 44 Cummington Street, Boston, Massachusetts 02215, USA.
Jaya Srivastava
Brian Fallica
Muhammad H Zaman
Boston University · USThe University of Texas at Austin · US

Funding

TRAINING IN BIOMOLECULAR PHARMACOLOGYT32GM008541 · NIGMS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI FARB, DAVID H · 1997 to 2022
$5.2M
Modeling bi-directional signaling and cytoskeletal dynamics in 3D cell migrationsU01CA177799 · NCI · BOSTON UNIVERSITY (CHARLES RIVER CAMPUS) · PI GERTLER, FRANK B, KAMM, ROGER D · 2013 to 2017
$3.0M
NCI NIH HHS U01 CA177799NCI NIH HHS U01-CA177799NIGMS NIH HHS T32 GM008541
6 · The paper itself

Abstract

The development of drugs to counter diseases related to cell migration has resulted in a multi-billion dollar endeavor. Unfortunately, few drugs have emerged from this effort highlighting the need for new methods to enhance assays to study, analyze and control cell migration. In response to this complex process, computational models have emerged as potent tools to describe migration providing a high throughput and low cost method. However, most models are unable to predict migration response to drug with direct application to in vitro experiments. In addition to this, no model to date has attempted to describe migration in response to drugs while incorporating simultaneously protein signaling, proteolytic activity, and 3D culture. In this paper, we describe an integrated computational approach, in conjunction with in vitro observations, to serve as a platform to accurately predict migration in 3D matrices incorporating the function of matrix metalloproteinases (MMPs) and their interaction with the Extracellular signal-related kinase (ERK) signaling pathway. Our results provide biological insight into how matrix density, MMP activity, integrin adhesions, and p-ERK expression all affect speed and persistence in 3D. Predictions from the model provide insight toward improving drug combinations to more effectively reduce both speed and persistence during migration and the role of integrin adhesions in motility. In this way our integrated platform provides future potential to streamline and improve throughput toward the testing and development of migration targeting drugs with tangible application to current in vitro assays.

Indexed as

Models, TheoreticalAmidesButadienesCell LineCell MovementComputer SimulationEnzyme InhibitorsExtracellular MatrixExtracellular Signal-Regulated MAP KinasesHumansHydroxamic AcidsImmunoblottingIn Vitro TechniquesMatrix MetalloproteinasesMicroscopy, ConfocalNitrilesAmidesButadienesEnzyme InhibitorsExtracellular Signal-Regulated MAP KinasesHydroxamic AcidsmarimastatMatrix MetalloproteinasesNitrilesPyridinesRNA, Small InterferingU 0126Y 27632

Identifiers

PMID25174457
PMCPMC4172491
OpenAlexW2064707003

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.